Guangming Li

1665 Kongjiang Road
Shanghai, 200092, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Discovery and optimization of novel TEAD inhibitors for in vivo investigation against hepatocellular carcinoma.

Discovery and optimization of novel TEAD inhibitors for in vivo investigation against hepatocellular carcinoma.

Journal: European journal of medicinal chemistry

Published: March 11, 2026

Disinfection Byproducts, Oxidative Stress, and Sleep Quality among Healthy Chinese Men.

Disinfection Byproducts, Oxidative Stress, and Sleep Quality among Healthy Chinese Men.

Journal: Environment & health (Washington, D.C.)

Published: July 11, 2025

Exogenous Metals Indirectly Affect Human Semen Quality via Immune Cells at Single-Cell Resolution.

Exogenous Metals Indirectly Affect Human Semen Quality via Immune Cells at Single-Cell Resolution.

Journal: Environment & health (Washington, D.C.)

Published: March 21, 2025

Targeting the Intestinal Microbiota: A Novel Direction in the Treatment of Inflammatory Bowel Disease.

Targeting the Intestinal Microbiota: A Novel Direction in the Treatment of Inflammatory Bowel Disease.

Journal: Biomedicines

Published: September 22, 2024

Blood trihalomethane and urinary haloacetic acid concentrations in relation to hypertension: An observational study among 1162 healthy men.

Blood trihalomethane and urinary haloacetic acid concentrations in relation to hypertension: An observational study among 1162 healthy men.

Journal: Journal of hazardous materials

Published: May 14, 2024

Hepatocyte-specific CCAAT/enhancer binding protein α restricts liver fibrosis progression.

Hepatocyte-specific CCAAT/enhancer binding protein α restricts liver fibrosis progression.

Journal: The Journal of clinical investigation

Published: November 01, 2022

Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light.

Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light.

Journal: Current treatment options in oncology

Published: October 10, 2022

Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis.

Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis.

Journal: Acta pharmacologica Sinica

Published: October 03, 2020

Hepatitis B-related glomerulonephritis and optimization of treatment.

Hepatitis B-related glomerulonephritis and optimization of treatment.

Journal: Expert review of gastroenterology & hepatology

Published: January 18, 2020

Protective Effects of Oridonin on Acute Liver Injury via Impeding Posttranslational Modifications of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in the Toll-Like Receptor 4 (TLR4) Signaling Pathway.

Protective Effects of Oridonin on Acute Liver Injury via Impeding Posttranslational Modifications of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in the Toll-Like Receptor 4 (TLR4) Signaling Pathway.

Journal: Mediators of inflammation

Published: June 01, 2019

Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease.

Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease.

Journal: BioMed research international

Published: November 27, 2018

p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization.

p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization.

Journal: Theranostics

Published: October 16, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026